Effect of Moxibustion Therapy Combined with Cefaclor in Children with Acute Mesenteric Lymphadenitis and Spleen Stomach Deficiency Cold Syndrome
Objective To observe the effect of moxibustion therapy combined with cefaclor in the treatment of children with acute mesenteric lymphadenitis (AML) with spleen stomach deficiency cold syndrome. Methods A total of 76 children with AML spleen stomach deficiency cold syndrome admitted to our hospital from January 2021 to January 2023 were selected and randomly divided into a control group and an observation group,with 38 cases in each group. The control group was treated with cefaclor,while the observation group received moxibustion therapy on the basis of the control group,both groups received continuous treatment for 2 weeks. Compare the clinical symptom scores,lymph node size,and clinical efficacy between two groups. Results After treatment,the observation group had lower abdominal pain (1.15±0.60) points,vomiting score (1.15±0.60) points,fever score (1.25±0.54) points,constipation score (1.48±0.60) points,and poor appetite score (1.47±0.54) points scores than (2.32±0.85) points,(2.12±0.74) points,(1.86±0.63)points,(2.15±0.97)points,and (2.10±0.84) points of the control group,with statistical significance (P<0.05);the transverse diameter and longitudinal diameter of lymph nodes in the observation group were (1.67±0.63)mm and (3.76±1.25)mm,respectively,which were shorter than (2.33±0.84)mm and (5.58±2.42)mm in the control group,with statistical significance (P<0.05). The total effective rate of the observation group was 97.37％,which was higher than 78.95％ of the control group,and the difference was statistically significant (P<0.05). Conclusion The combination of moxibustion therapy and cefaclor has a definite therapeutic effect on AML with spleen stomach deficiency cold syndrome,which can effectively reduce the size of lymph nodes and improve clinical symptoms.
NETL
NSTL
万方数据
